Ribociclib Real-world Treatment Patterns and Clinical Outcomes Among Women With HR+/HER2- Advanced or Metastatic Breast Cancer in France
Clinical trial NCT05697146 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05697146
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-12-13
- Primary completion
- 2028-06-30
- Enrollment
- 1019
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.